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ABSTRACT
Objective: The present study was aimed to assess the drug prescribing pattern and analyze the prescribing pattern using Beers criteria among elderly 
patients aged over 60 years.
Methods: The present study was a prospective observational study conducted in the outpatient Department of General Medicine in a tertiary care 
hospital for the duration of 3 months. Institutional Ethics Committee approval was taken prior to the initiation of the study. Written informed consent 
was taken from each study subject. A total of 287 subjects who were aged more than 60 years recruited into the study. The data were collected in a 
pre-structured case record form. Subjects’ demographic details, medical conditions, and drugs included in prescription their dose; frequency, and 
duration were noted in the case record form.
Results: Among 287 subjects, 91.64% subjects belonged to 61-70 years age group, remaining 8.36% subjects were >71 year older, and 57.14% 
were males and 42.86% were females. Hypertension (HTN) was the most common cause of attending hospital followed by diabetes mellitus, central 
nervous system disorders, respiratory, cardiovascular disorders other than HTN, and infectious diseases. A total of 1574 formulations containing 
1669 active ingredients and 90 fixed dose drug combinations were prescribed. And only 152 formulations were prescribed from the outside hospital 
formulary. The average number of drugs per prescription was 5.48±2.00. Among the individual drugs, vitamin B complex was the most commonly 
prescribed drug.
Conclusion: There is a need for more rational prescribing and to form guidelines for safe and effective use of medicines in elderly patients.
Keywords: Beers criteria, Elderly patients, Drug utilization pattern.
INTRODUCTION
In world, geriatric population occupies significant percentage with over 
60% of the elderly population found in developing countries. The number 
of elderly persons aged 60 or over in developing countries expected to 
rise from 510 million in 2011 to 1.6 billion in 2050 [1]. In India, 7.4% of 
the population is more than 60 years old, and there is a sharp increase 
in elderly population in India [2]. It is estimated to rise to 12.4% by the 
year 2026 [2]. Elder people constitute a heterogeneous group due to 
age-related changes in pharmacokinetic and pharmacodynamic profiles 
of drugs [3]. Age-related changes in body weight, body composition, and 
decrease in body water and increase in body fat, decrease in renal and 
hepatic functions alter the pharmacokinetics of drugs. And up regulation 
and down regulation of the receptors alter pharmacodynamics of drugs 
and there is increased sensitivity to some of the drugs acting on central 
nervous system (CNS). Elderly persons use more medications than other 
age groups. They are associated with higher rates of chronic illness. 
Most of the elderly live with one or more chronic conditions. Hence, 
polypharmacy is the most common problem in elderly. Polypharmacy is 
the use of at least one potentially inappropriate drug or presence of five 
or more concurrent medications in one prescription [4,5].
Polypharmacy in elderly patients exposes them to increased drug 
interactions, increased adverse drug reactions (ADRs), and increased 
health care cost [6]. ADRs are more prevalent in elderly and most are 
type A reactions predictable from the known pharmacology of the 
drug and are mostly avoidable [7-9]. Elderly patients also suffer from 
depression and degenerative diseases such as Alzheimer’s disease 
affecting compliance.
Pattern of drug use, quality of drug use, determinants of drug use, 
and outcomes of drug use are important insights of drug utilization 
research. Drug utilization research is defined by the WHO as “study 
of marketing, distribution, prescription, and use of drugs in society, 
with special emphasis on the resulting medical, social, and economic 
consequences” [10]. Drug utilization ultimately assesses whether drug 
therapy is rational or not.
For the safe and appropriate use of medicines in an elderly, a criteria 
has been created by Beers [11]. Beers criteria were defined by Beers 
in 1991 and was updated in 1997, 2003 and 2012. The Beers criteria 
consist of medications to be avoided in the elderly irrespective of 
patient’s diagnosis, and those that should be avoided due to drug-
disease drug-syndrome interactions and those drugs that should 
be used with caution in older [12]. The Beers criteria also have its 
deficiencies this led to the development of the newer tools such as the 
screening tools of older persons prescriptions and screening tool to 
alert doctors to right treatment [13,14].
The aim of present study was to assess the drug prescribing pattern 
and analyze the prescribing pattern using Beers criteria among elderly 
patients aged over 60 years in Osmania General Hospital, Hyderabad, a 
tertiary hospital.
METHODS
The present study was a prospective observational study conducted 
in the outpatient department of General Medicine, Osmania General 
Hospital, for the duration of 3 months. The study protocol was approved 
by the Institutional Ethics Committee prior to starting of the study. 287 
subjects were included in the study. Written informed consent was 
taken from each subject before recruiting into the study.
Inclusion criteria
Subjects who aged more than 60 years and attending medicine 
outpatient department were included in the study
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Exclusion criteria
Subjects less than 60 years old and who were not willing to give 
informed consent were excluded from the study.
The data from all the study subjects were collected daily in OP timings, 
i.e., 9 am to 1 pm in a pre-structured case record form. Subjects 
demographic details include subject initials, age, gender, socioeconomic 
status were collected and medical conditions for which the subject was 
attending the hospital, all investigations, all drugs in the prescription, 
their dose, duration, frequency were noted in the structured case 
record form. The subjects were monitored for ADRs.
Data analysis
Age, gender wise distribution of subjects, frequency distribution of 
medical conditions, total number of drugs per prescription for each 
subject, average number of drugs per prescription expressed as mean 
and standard deviation, number of fixed dose drug combinations 
(FDCs), number of drugs prescribed from hospital formulary, system 
wise distribution of drugs, most commonly prescribed drugs in this 
study and their WHO Anatomical Therapeutic Classification (ATC), 
defined daily doses (DDDs) were analyzed. Based on the number of 
drugs in the prescription, they were divided into subjects prescribed 
with <5 drugs, 5-8 drugs and more than 8 drugs. Prescriptions with 
>5 drugs were considered as polypharmacy.
Frequency of prescriptions of potentially inappropriate medications 
(PIMs) was analyzed using 2012 updated Beers criteria [12].
Statistical analysis
Mostly descriptive statistics was used. Data were analyzed by the Chi-
square test for comparing the proportions of polypharmacy between 
genders and to test the association between polypharmacy and 
frequency of prescriptions of PIMs. SPSS software version 24 was used 
to analyze the data.
RESULTS
Among 287 subjects who were aged >60 years and attending medicine 
outpatient department, 263 (91.64%) subjects belonged to 61-70 years 
age group, remaining 24 (8.36%) subjects were >71 years older. The 
minimum age was 61 years and maximum age 90 years. Out of 287 
subjects, 164 (57.14%) were males and 123 (42.86%) were females. 
Maximum subjects were attended the department for hypertension (HTN) 
(63.07%) followed by diabetes mellitus (DM) (24.04%), central nervous 
system disorders, respiratory, cardiovascular disorders other than HTN, 
and infectious diseases (Table 1). 130 (45.3%) subjects had only one 
condition remaining 157 (54.7%) had two or more co-morbid conditions.
A total of 1574 formulations were prescribed containing 1669 active 
ingredients. Of the 1574 formulations, 90 were FDCs and 1484 
contained only one active ingredient. And only 152 formulations were 
prescribed from the outside hospital formulary. The average number of 
drugs per prescription was 5.48±2.00. Out of 287 subjects, 91 (31.71%) 
subjects had prescribed with less than 5 drugs, 178 subjects with 5-8 
drugs and 18 subjects with more than 8 drugs. The minimum number 
of drugs per prescription was 1 and the maximum was 12 drugs (Fig. 1).
Polypharmacy is considered as more than 5 drugs per prescription. 
In this study, polypharmacy was present in 196 (68.29%) subjects; 
84 female and 112 male subjects had polypharmacy (Fig. 2).
The difference in polypharmacy between male and female subjects was 
not statistically significant (p=1.000). The system wise distribution of 
drugs was shown in Table 2. Drugs acting on cardiovascular system 
(CVS) were the most frequently prescribed drugs (437 subjects), 
followed by vitamins, minerals, and dietary supplements (302 subjects), 
drugs acting on gastrointestinal tract (231 subjects), drugs acting on 
hematological system (126 subjects) together constitutes 69.63% and 
others contributes to the remaining 30.37%.
Vitamin B complex (155 subjects) was the most frequently prescribed 
drug, followed by enalapril 5 mg (102 subjects), ranitidine 150 mg 
(101 subjects), pantoprazole 40 mg (94 subjects), amlodipine 5 mg 
(90 subjects), aspirin 150 mg (81 subjects), calcium lactate 300 mg 
(76 subjects), atorvastatin (71 subjects), diclofenac sodium 50 mg 
(61 subjects), and metformin 500 mg (58 subjects). These most 
commonly prescribed drugs and their ATC code, WHO DDD measure 
and number of DDDs was shown in Table 3.
Among the antihypertensive drugs, enalapril was the most commonly 
prescribed drug followed by Amlodipine and among the hypoglycemic 
agents metformin was the most commonly prescribed drug followed 
Table 1: Frequency distribution of diseases/conditions
S. No. Disease/condition Number of patients (%)
1 HTN (all cases) 181 (63.07)
2 DM (all cases) 69 (24.04)
3 HTN+DM 
(with or without co 
morbid conditions)
48 (16.72)
4 Central nervous 
system diseases
66 (23)







7 Infectious diseases 31 (10.8)




DM: Diabetes mellitus, HTN: Hypertension
Table 2: System wise distribution of drugs
S. No. Category of drugs Number of 
drugs (%)
1 Drugs acting on cardiovascular system 437 (27.76)
2 Vitamins, minerals and dietary supplements 302 (19.19)
3 Drugs acting on gastrointestinal system 231 (14.68)
4 Drugs acting on hematological system 126 (8)
5 Analgesics and anti-inflammatory drugs 115 (7.31)
6 Drugs acting on respiratory system 103 (6.54)
7 Drugs acting on endocrinal system 98 (6.23)
8 Drugs acting on central nervous system 74 (4.7)
9 Antimicrobial drugs 56 (3.56)
10 Others 32 (2.03)
Fig. 1: Frequency of number of drugs per prescription
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by glibenclamide. Amoxicillin and potassium clavulanate combination 
was the most commonly prescribed antimicrobial drug. Deriphyllin 
(theophylline+etophylline) was the most commonly prescribed among 
respiratory drugs and phenytoin sodium was the commonly used 
antiepileptic drug. Total number of injections prescribed was 16, which 
were injection insulin, deriphyllin, and hydrocortisone.
Out of 1574 formulations, 67 formulations were PIMs identified in 58 
subjects according to 2012 updated Beer’s criteria. Antihistamines were 
the most frequently prescribed PIMs (21 subjects), followed by non-
steroidal anti-inflammatory drugs (NSAIDS), digoxin, spironolactone, 
chlordiazepoxide, amitryptylin, clonidine, alprazolam, amiodarone, 
phenobarbital (Table 4).
About 50 subjects had only one PIM, 7 subjects had two PIMs and 
only one subject had three PIMs. There was statistically significant 
association between polypharmacy and PIMs use in elderly population 
(p<0.05).
During the study period, ADRs were recorded in four patients. Three 
subjects complained of dry cough due to enalapril and one patient 
complained of gynecomastia due to spironolactone. All were probable 
according to the WHO causality assessment [15].
DISCUSSION
Elderly population is growing rapidly in the world, especially in the 
developing countries. In developing countries persons aged more 
than 60 years were considered as elderly people. In India, due to low 
life expectancy compared to developed countries, normal retirement 
age and eligibility for senior citizenship and according to literature, 
60 years is considered as cut off age for elderly [16]. Most of the elderly 
patients suffer from more than one chronic condition and it leads to 
polypharmacy. This study was undertaken to analyze the prescribing 
pattern in elderly and problems related to it.
In this study, 57.14% subjects belonged to male gender, higher than 
female subjects (42.86%). Almost all subjects were uneducated and 
belonged to low socioeconomic status. The most common condition for 
attending hospital was HTN; this is similar to other studies conducted 
in India [17]. Most commonly affected system was CVS followed by CNS 
and respiratory system. In CVS, most common condition was the HTN 
followed by coronary artery disease and left ventricular dysfunction. In 
CNS, cerebrovascular disease was most common, followed by epilepsy. 
And only 10.8% subjects had infectious diseases and remaining were 
non-communicable diseases. This shows an increasing trend of non-
communicable diseases in India.
In the present study, FDCs were only 5.71%; this was very less 
compared to other studies [18]. Most common FDCs were deriphyllin 
(etophylline and theophylline) followed by amoxicillin and potassium 
clavulanate combination. And 90.34% drugs were prescribed from 
the local hospital formulary. This reflects more rational prescribing of 
drugs.
The average number of drugs per prescription was 5.48±2.00, this 
coincides with other studies [19]. Polypharmacy was present in 
68.29% subjects. In a study by Shah et al., average number of drugs per 
prescription was 7.3±4.39 and polypharmacy was present in 75.25% 
patients [20]. Compared to this study, in our study, average number of 
drugs per prescription and polypharmacy was less. And polypharmacy 
increases PIMs. This polypharmacy leads to increased health care costs, 
adverse drug responses, drug interactions, non-adherence, and decline 
in functional status and cognitive impairment [21]. Hence, measures to 
control polypharmacy must be taken to avoid consequences.
Clinical trials are done in ideal conditions and mostly involve younger 
adults. Pharmacokinetics and pharmacodynamics of the drugs are 
different in elderly population. Hence, there is a need to enroll elderly 
patients in clinical trials to avoid unnecessary drug related events. 
Most of the elderly people suffer from hepatic and renal failures so the 
doses of the drugs that are eliminated by these routes must be adjusted 
Table 3: Most commonly prescribed drugs and their DDD
S. No. Drug Number of prescriptions ATC code WHO DDD Number of DDDs
1 B complex 155 A11EA - -
2 Enalapril 102 C09AA02 10 mg 42.75
3 Ranitidine 101 A02BA02 0.3 g 50.5
4 Pantoprazole 94 A02BC02 40 mg 94
5 Amlodipine 90 C08CA01 5 mg 90.5
6 Aspirin 81 B01AC06 1 tab=1 UD 81
7 Calcium lactate 76 A12AA05 2 g 11.4
8 Atorvastatin 71 C10AA05 20 mg 98.5
9 Diclofenac sodium 61 M01AB05 0.1 g 30.5
10 Metformin 58 A10BA02 2 g 14.5
DDD: Defined daily dose, ATC: Anatomical therapeutic classification
Table 4: Frequency of the prescription of PIMs











PIM: Potentially inappropriate medications, NSAIDS: Non-steroidal 
anti-inflammatory drugs
Fig. 2: Polypharmacy in male and female
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accordingly to avoid adverse consequences. In an observational study, 
for admission into intensive care unit due to unpreventable adverse 
drug events, compared to controls study group took more number of 
drugs [22].
Among the drugs, B complex vitamin was the most commonly prescribed 
drug. According to category wise distribution vitamins, minerals, and 
dietary supplements were the second most commonly prescribed 
drugs. Hence, this suggests elderly also suffer from nutritional 
deficiencies and in our study most complained of generalized body 
pains. There was increase in the use of drugs that decrease gastric 
acidity such as ranitidine and pantoprazole. This suggests more 
number of drugs per prescription led to increased prescription of 
these gastrointestinal drugs to avoid gastric irritation. Most commonly 
prescribed cardiovascular drug was enalapril followed by amlodipine. 
In a study on prescribing patterns of antihypertensive drugs in geriatric 
patients, most commonly prescribed drug was amlodipine, which was 
second most common in our study [23]. In the present study, most 
commonly prescribed drug for type 2 DM was metformin, similar to 
other study in diabetes patients attending tertiary care hospital in 
Navi Mumbai [24]. Among antiepileptic drugs, phenytoin was the most 
commonly prescribed drug despite its various drug-drug interactions. 
Similarly, phenytoin was the most commonly prescribed drug in a study 
by Pathak et al. [25].
Beers criteria were used to monitor PIMs in the present study. 
Antihistamines were the most common PIMs among them, 
chlorpheniramine maleate was the most commonly prescribed PIM 
in our study. First generation of antihistamines are included in Beers 
criteria so other alternative drugs such as second and third generation 
antihistamines can be used in elderly patients. Second most commonly 
prescribed PIMs were NSAIDS. Beers criteria suggest that non COX 
selective NSAIDS must be avoided in high risk groups because these 
drugs increase gastrointestinal bleeding. Digoxin and spironolactone 
were prescribed in more than the recommended dosage according 
to Beers criteria in our study. These drugs must be used in dosage 
of <0.125 mg/day and less than 25 mg/day in elderly patients. 
Antipsychotics, tricyclic antidepressants and barbiturates must be 
avoided in elderly [12].
CONCLUSION
The present study analyzed the commonly encountered problems in 
elderly, number of drugs per prescription, most commonly prescribed 
drugs and use of inappropriate medication in geriatric patients. So for, 
safe and effective use of medicines in an elderly, we need guidelines 
to avoid PIMs and drug related problems. And there is a need for 
awareness among physicians regarding medication use in elderly.
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